Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -14.06% is 45% above its 5-year average of -25.64%, near the high end of its 5-year range (-33.65%–-13.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.71% above its 12-month average of -19.18%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -14.06%.
RETURN ON INVESTED CAPITAL (ROIC)
-14.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-19.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-22.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-25.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-23.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-21.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.71%
CURRENT VS 3Y AVG
+36.76%
CURRENT VS 5Y AVG
+45.17%
CURRENT VS 10Y AVG
+40.46%
CURRENT VS 15Y AVG
+35.32%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+60.56%
vs the sector median at left
Standard BioTools Inc.
Market Cap
$286.36M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-19.18%
3Y Avg
-22.23%
5Y Avg
-25.64%
Market Cap
$285.83M
Return on Invested Capital (ROIC)
-49.76%
TTM Avg
-54.76%
3Y Avg
-73.23%
5Y Avg
-84.98%
Market Cap
$285.58M
Return on Invested Capital (ROIC)
-20.40%
TTM Avg
-43.02%
3Y Avg
-57.92%
5Y Avg
-48.43%
Market Cap
$283.58M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-38.45%
3Y Avg
-31.16%
5Y Avg
-81.63%
Market Cap
$283.69M
Return on Invested Capital (ROIC)
-15.69%
TTM Avg
-4.06%
3Y Avg
-9.73%
5Y Avg
-12.88%
Market Cap
$281.92M
Return on Invested Capital (ROIC)
-27.62%
TTM Avg
-16.38%
3Y Avg
-32.77%
5Y Avg
-39.71%
Market Cap
$291.03M
Return on Invested Capital (ROIC)
-129.90%
TTM Avg
-509.42%
3Y Avg
-303.54%
5Y Avg
-247.13%
Market Cap
$291.39M
Return on Invested Capital (ROIC)
-136.49%
TTM Avg
-130.82%
3Y Avg
-85.38%
5Y Avg
-76.42%
Market Cap
$273.07M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Standard BioTools Inc. (LAB) | $286.36M | -14.06% | -19.18% | -22.23% | -25.64% |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.83M | -49.76% | -54.76% | -73.23% | -84.98% |
| Sagimet Biosciences Inc. (SGMT)vs › | $285.58M | -20.40% | -43.02% | -57.92% | -48.43% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.58M | -61.10% | -38.45% | -31.16% | -81.63% |
| Aurora Cannabis Inc. (ACB)vs › | $283.69M | -15.69% | -4.06% | -9.73% | -12.88% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.92M | -27.62% | -16.38% | -32.77% | -39.71% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $291.03M | -129.90% | -509.42% | -303.54% | -247.13% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.39M | -136.49% | -130.82% | -85.38% | -76.42% |
| Scribe Therapeutics Inc. (SCTX)vs › | $273.07M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $272.78M | -59.50% | -188.11% | -308.62% | -250.56% |
ROIC
-14.1%
ROE
-16.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -14.06% |
| 2026-03-31 | -13.15% |
| 2025-12-31 | -20.07% |
| 2025-09-30 | -24.14% |
| 2025-06-30 | -24.50% |
| 2025-03-31 | -22.74% |
| 2024-12-31 | -28.36% |
| 2024-09-30 | -23.31% |
| 2024-06-30 | -20.79% |
| 2024-03-31 | -16.91% |
| 2023-12-31 | -28.03% |
| 2023-09-30 | -26.10% |
| 2023-06-30 | -26.85% |
| 2023-03-31 | -31.79% |
| 2022-12-31 | -33.30% |
| 2022-09-30 | -28.78% |
| 2022-06-30 | -24.33% |
| 2022-03-31 | -33.65% |
| 2021-12-31 | -29.02% |
| 2021-09-30 | -31.12% |
| 2021-06-30 | -24.93% |
| 2021-03-31 | -22.02% |
| 2020-12-31 | -18.87% |
| 2020-09-30 | -15.46% |
| 2020-06-30 | -21.17% |
| 2020-03-31 | -20.63% |
| 2019-12-31 | -22.35% |
| 2019-09-30 | -22.78% |
| 2019-06-30 | -20.93% |
| 2019-03-31 | -19.33% |
| 2018-12-31 | -18.10% |
| 2018-09-30 | -21.45% |
| 2018-06-30 | -22.37% |
| 2018-03-31 | -22.65% |
| 2017-12-31 | -22.99% |
| 2017-09-30 | -25.88% |
| 2017-06-30 | -28.73% |
| 2017-03-31 | -27.51% |
| 2016-12-31 | -26.43% |
| 2016-09-30 | -23.65% |
| 2016-06-30 | -18.89% |
| 2016-03-31 | -16.99% |
| 2015-12-31 | -14.71% |
| 2015-09-30 | -13.19% |
| 2015-06-30 | -14.31% |
| 2015-03-31 | -13.31% |
| 2014-12-31 | -13.71% |
| 2014-09-30 | -11.99% |
| 2014-06-30 | -9.69% |
| 2014-03-31 | -7.38% |
| 2013-12-31 | -18.01% |
| 2013-09-30 | -17.64% |
| 2013-06-30 | -16.40% |
| 2013-03-31 | -16.57% |
| 2012-12-31 | -17.69% |
| 2012-09-30 | -16.59% |
| 2012-06-30 | -32.26% |
| 2012-03-31 | -33.70% |
| 2011-12-31 | -27.27% |
| 2011-09-30 | -24.60% |
| 2011-06-30 | -21.84% |
| 2011-03-31 | -16.89% |
| 2010-12-31 | -104.28% |
| 2010-09-30 | -119.63% |
